Abstract: Described herein are methods for the determination of patient mortality from alcoholic hepatitis in biosamples by NMR spectroscopy and more specifically for the determination of a Z index score based on lipoprotein constituent LP-Z in blood plasma and serum.

Abstract: Surface of a sample of a heterogeneous material and of samples with known thermal conductivity and thermal diffusivity is heated by a heating spot created by a heater and moving along the surfaces of all samples to determine thermal conductivity and thermal diffusivity of the heterogeneous material. Temperatures of heated surface of all samples are registered by three temperature sensors. Return of the heater and the sensors to the initial position is used for scanning with additional measurements of the sample thermal conductivity for a layer of the sample with depth and width different from those of a layer where thermal conductivity is measured during the forward direction.

Abstract: Surface of a sample of a heterogeneous material and of samples with known thermal conductivity and thermal diffusivity is heated by a heating spot created by a heater and moving along the surfaces of all samples to determine thermal conductivity and thermal diffusivity of the heterogeneous material. Temperatures of heated surface of all samples are registered by three temperature sensors. Return of the heater and the sensors to the initial position is used for scanning with additional measurements of the sample thermal conductivity for a layer of the sample with depth and width different from those of a layer where thermal conductivity is measured during the forward direction.

Abstract: The invention features methods of diagnosing inflammatory disease based on the elevated presence microparticles (MP) expressing certain receptors. The invention also features methods of decreasing fibrosis in the liver by administering MP to subjects with liver fibrosis.

Abstract: The invention features methods of diagnosing inflammatory disease based on the elevated presence microparticles (MP) expressing certain receptors. The invention also features methods of decreasing fibrosis in the liver by administering MP to subjects with liver fibrosis.

Abstract: This invention relates to inhibition of ?v integrins, especially ?v?3 and ?v?6 integrins, by specific antagonists, preferably non-peptidic antagonists, related compounds and compounds with comparable specificity, that downregulate fibrogenesis by inhibiting cell migration and production of pro-fibrogenic molecules (e.g., collagens, TIMP-1) and cytokines (e.g., CTGF) by activated hepatic stellate cells/myofibroblasts, activated epithelia and endothelia. These antagonists alone or in combination with other agents can effectively prevent, mitigate or even reverse development of advanced fibrosis, such as fibrosis/cirrhosis of the liver and fibrosis of other organs, such as lungs, kidneys, intestine, pancreas, skin and arteries.

Abstract: A re-usable information recording medium provided with a sensitive layer which comprises a plurality of particles having a magnetically responsive position, and a retaining material embedding the particles and having a temperature dependent viscosity, the particles and the retaining material exhibiting light absorption spectra which are different one from the other.